SUNNYVALE, Calif., Jan. 17, 2016 (GLOBE NEWSWIRE) -- Silicon Valley Eye Physicians is proud to announce that they have acquired the revolutionary LipiFlow device to treat patients suffering with dry eye due to Meibomian Gland Dysfunction (MGD). Presently, the LipiFlow is the most innovative device available for treating MGD. The Meibomian glands are located in the eyelids: They are responsible for producing a protective layer of tear film. If these glands become blocked, the individual's tears evaporate quickly; thus, causing discomfort, irritation and, if left untreated, gland dropout.
When the structure and/or function of the Meibomian glands become compromised, MGD results. Diagnosing a patient with MGD requires a series of evaluations: One of which may be conducted using the LipiView interferometer. The LipiView interferometer is unique in that it is the only device of its kind. LipiView enables eye doctors to take images of the Meibomian glands and the tear film, allowing for an accurate evaluation of the Meibomian glands. The LipiView interferometer allows eye doctors to capture images to determine the thickness of the lipid component.
LipiFlow makes it possible for the physicians at Silicon Valley Eye Physicians to address gland blockages, which are the root cause of MGD. Although there are numerous options available for treating MGD, the only FDA-approved device for the removal of Meibomian gland blockages to restore function is LipiFlow. Treatment with LipiFlow involves utilizing an algorithm of heat application to the inner eyelids, in conjunction with massage, allowing for the removal of the Meibomian glands’ obstructions.
Dr. David Mark states that, “There are approximately 30 million people in the United States who are suffering with dry eye: The majority of these people find relief with temporary treatment methods, such as eye drops. Temporary relief was the only option for individuals with dry eye because until now, the root cause of dry eye was unclear; finally, after more than 25 years of research, the condition Meibomian Gland Dysfunction (MGD) was discovered. MGD is a chronic condition that progresses with time. We can now offer our patients who are diagnosed with MGD a more permanent solution with LipiFlow treatments.”
The Silicon Valley Eye Physicians’ clinics in Sunnyvale and Santa Clara are the only eye care clinics in Silicon Valley currently offering LipiFlow treatments. These clinics also offer routine eye exams (adults and children), prescription contact lenses, eyeglasses, LASIK eye surgery, screening and treatment for conditions like cataracts, glaucoma, diabetic eye disease, as well as cosmetic surgery for issues related to the eyelids. For more information visit them online at www.eyelink.com.
Silicon Valley Eye Physicians, 408-739-6200


Shell M&A Chief Exits After BP Takeover Proposal Rejected
Robinhood Expands Sports Event Contracts With Player Performance Wagers
Fortescue Expands Copper Portfolio With Full Takeover of Alta Copper
Strategy Retains Nasdaq 100 Spot Amid Growing Scrutiny of Bitcoin Treasury Model
SUPERFORTUNE Launches AI-Powered Mobile App, Expanding Beyond Web3 Into $392 Billion Metaphysics Market
Nomura Expands Alternative Assets Strategy With Focus on Private Debt Acquisitions
iRobot Files for Chapter 11 Bankruptcy Amid Rising Competition and Tariff Pressures
CMOC to Acquire Equinox Gold’s Brazilian Mines in $1 Billion Deal to Expand Precious Metals Portfolio
Trump Sues BBC for Defamation Over Edited Capitol Riot Speech Clip
HSBC’s $13.6 Billion Take-Private Offer for Hang Seng Bank Gains Board Backing
MetaX IPO Soars as China’s AI Chip Stocks Ignite Investor Frenzy
Coca-Cola’s Proposed Sale of Costa Coffee Faces Uncertainty Amid Price Dispute
EU Signals Major Shift on 2035 Combustion Engine Ban Amid Auto Industry Pressure
Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation
SpaceX Begins IPO Preparations as Wall Street Banks Line Up for Advisory Roles
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease 



